Pharmsynthez (MOEX: LIFE)
Russia
· Delayed Price · Currency is RUB 4.505
+0.415 (10.15%)
At close: Jul 8, 2022
Pharmsynthez Cash Flow Statement
Financials in millions RUB. Fiscal year is January - December.
Millions RUB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | 2017 - 2013 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '23 Jun 30, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | 2017 - 2013 |
| Net Income | -303.66 | -207.49 | -697.55 | -524.81 | -1,812 | -417.7 | Upgrade
|
| Depreciation & Amortization | 28.04 | 27.51 | 31.96 | 44.4 | 25.94 | 54.59 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | 1.21 | -6.01 | 14.76 | 7.33 | Upgrade
|
| Loss (Gain) From Sale of Investments | 5.13 | 19.49 | 388.99 | 196.11 | 1,577 | 0.58 | Upgrade
|
| Loss (Gain) on Equity Investments | 8.55 | 14.38 | 17.04 | 56.2 | 305.35 | 271.36 | Upgrade
|
| Provision & Write-off of Bad Debts | -0.02 | 0.57 | 160.14 | - | - | - | Upgrade
|
| Other Operating Activities | 181.49 | 46.81 | -8.67 | 24.66 | -126.89 | -353.37 | Upgrade
|
| Change in Accounts Receivable | -29.11 | 9.86 | 15.76 | 74.1 | -57.19 | 93.06 | Upgrade
|
| Change in Inventory | -58.63 | -8.96 | 9.63 | 7.69 | 117.75 | -6.69 | Upgrade
|
| Change in Accounts Payable | -145.02 | 107.15 | -36.82 | -105.1 | -109.93 | 232.76 | Upgrade
|
| Change in Other Net Operating Assets | -12.66 | -12.66 | -0.8 | - | -8.74 | - | Upgrade
|
| Operating Cash Flow | -325.89 | -3.35 | -62.7 | -232.76 | -68.89 | -112.76 | Upgrade
|
| Capital Expenditures | -36.69 | -3.47 | -0.28 | -9.68 | -14.5 | -19.35 | Upgrade
|
| Investing Cash Flow | -37.53 | -4.47 | -1.9 | -9.68 | -14.5 | -19.35 | Upgrade
|
| Long-Term Debt Issued | - | 7.85 | 89.44 | 107.71 | 143.6 | 56.1 | Upgrade
|
| Total Debt Issued | 2.65 | 7.85 | 89.44 | 107.71 | 143.6 | 56.1 | Upgrade
|
| Long-Term Debt Repaid | - | -33.56 | -21.32 | -16.09 | -5.47 | -3.17 | Upgrade
|
| Total Debt Repaid | -108.4 | -33.56 | -21.32 | -16.09 | -5.47 | -3.17 | Upgrade
|
| Net Debt Issued (Repaid) | -105.75 | -25.71 | 68.11 | 91.62 | 138.13 | 52.93 | Upgrade
|
| Issuance of Common Stock | 727.63 | 23.74 | - | 87.26 | - | - | Upgrade
|
| Other Financing Activities | - | - | - | - | 1.5 | 65.67 | Upgrade
|
| Financing Cash Flow | 621.87 | -1.97 | 68.11 | 178.88 | 139.63 | 118.6 | Upgrade
|
| Foreign Exchange Rate Adjustments | -3.87 | 3.68 | 1.37 | 7.05 | 6.02 | 13.69 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | -0 | -0 | 0 | 0 | - | - | Upgrade
|
| Net Cash Flow | 254.58 | -6.12 | 4.88 | -56.52 | 62.26 | 0.17 | Upgrade
|
| Free Cash Flow | -362.58 | -6.82 | -62.97 | -242.45 | -83.39 | -132.12 | Upgrade
|
| Free Cash Flow Margin | -105.35% | -1.80% | -14.37% | -65.23% | -28.65% | -37.81% | Upgrade
|
| Free Cash Flow Per Share | -1.21 | -0.02 | -0.21 | -0.81 | -0.28 | -0.44 | Upgrade
|
| Cash Interest Paid | 6.98 | 4.97 | 11.23 | 6.52 | 1.94 | 1.74 | Upgrade
|
| Cash Income Tax Paid | - | - | - | 0.11 | - | - | Upgrade
|
| Levered Free Cash Flow | -253.2 | 20.98 | 87.89 | -339.32 | -65.2 | -46.71 | Upgrade
|
| Unlevered Free Cash Flow | -227.36 | 46.81 | 110.63 | -320.85 | -59.3 | -40.52 | Upgrade
|
| Change in Net Working Capital | 147.38 | -101.5 | -221.17 | 263.46 | -65.35 | -41.13 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.